For example, in a study on pancreatic cancer cell lines, the HDAC inhibitor vorinostat (also known as suberoylanilide hydroxamic acid, or SAHA) had an additive effect of decreasing growth when tested together with gemcitabine [5]. Here, HDAC9 is linked to pancreatic neoplasm.